Real-time enrollment status for this high-grade glioma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06161974 |
| Recruiting Status | Recruiting |
| Condition | High-Grade Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Rigel Pharmaceuticals |
| Last Updated on CT.gov | February 21, 2025 (Feb 21, 2025) |
As of March 2, 2026: Clinical trial NCT06161974 is currently recruiting participants. This clinical trial study for high-grade glioma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Rigel Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06161974 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06161974 was last updated Feb 21, 2025 (February 21, 2025). HelloStudys verifies this status automatically.